Clinical Trial

Effects of X Box Kinect 360 in Alzheimer's Disease

Study acronym: AD Alzheimer'
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).
Trial Details
NCT Number NCT07673263
Lead Sponsor Ziauddin University
Conditions Alzheimer s Disease
Enrollment 38 participants
Start Date 2026-06-24
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-29